An automated controlled-release device for intravaginal hormone delivery

被引:6
|
作者
Masello, M. [1 ]
Ren, Y. [2 ]
Erickson, D. [2 ]
Giordano, J. O. [1 ]
机构
[1] Cornell Univ, Dept Anim Sci, Ithaca, NY 14853 USA
[2] Cornell Univ, Sibley Sch Mech & Aerosp Engn, Ithaca, NY 14853 USA
来源
JDS COMMUNICATIONS | 2020年 / 1卷 / 01期
基金
美国食品与农业研究所;
关键词
DAIRY-COWS; ARTIFICIAL-INSEMINATION; SYNCHRONIZATION; INSTILLATION; POSTPARTUM; OVULATION; ESTRUS; PROSTAGLANDIN-F2-ALPHA; FERTILITY;
D O I
10.3168/jdsc.2020-18816
中图分类号
S8 [畜牧、 动物医学、狩猎、蚕、蜂];
学科分类号
0905 ;
摘要
Our objective was to develop and validate an electronically controlled hormone-delivery device for reproductive control of cattle. After development and in vitro testing of a prototype device for intravaginal (IVG) hormone release, we aimed to demonstrate the feasibility of inducing luteal regression by automated treatment with PGF 2 alpha . The IVG device comprises an outer 3D-printed plastic housing, fluid reservoirs connected to delivery pumps and tubing, a programmable circuit board, and a retention mechanism. For in vitro testing, 4 pumps were programmed to release different target volumes (0.1, 0.2, 0.5, 1.0, and 2.0 mL) in 4 replicates (n = 80). A Bland-Altman plot was constructed to assess the magnitude of disagreement between expected and delivered volumes. Observations fell within acceptable limits of agreement (1.96 standard deviations) >95% of the time, indicating overall good agreement (mean difference = -0.005 mL). To assess in vivo performance of the IVG device, lactating Holstein cows with at least 1 corpus luteum >= 15 mm in diameter were randomly allocated to 1 of 3 treatments: (1) IM-PGF (n = 6): two 25-mg intramuscular doses of PGF 2 alpha 24 h apart; (2) DEV-PGF (n = 6): four 25-mg doses of PGF 2 alpha released automatically by the IVG device at 10- or 12-h intervals; and (3) DEV-CTL (n = 4): insertion of an empty IVG device (placebo control). Blood samples were collected at 0, 12, 24, 36, 48, and 72 h after treatment. Data were analyzed by ANOVA with repeated measures. All devices (10/10) remained in situ until removed at 48 h. Progesterone (P4) concentrations from 0 to 72 h were affected by treatment, time, and their interaction. Concentrations of P4 did not differ at time 0 but differed from 24 to 72 h: cows in IM-PGF and DEV-PGF had lesser P4 than cows in DEV-CTL. Conversely, P4 did not differ for IM-PGF and DEV-PGF during the experiment. We conclude that the current IVG hormone-releasing device prototype can be programmed to automatically release PGF 2 alpha for successful induction of luteal regression in lactating dairy cows.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Erratum to "An automated controlled-release device for intravaginal hormone delivery" (JDS Commun. 1:15-20)
    Masello, M.
    Ren, Y.
    Erickson, D.
    Giordano, J. O.
    JDS COMMUNICATIONS, 2022, 3 (02): : 161 - 161
  • [2] EVALUATION OF A CONTROLLED-RELEASE MEMBRANE INFUSION DEVICE FOR DELIVERY OF GENTAMICIN
    NAHATA, MC
    DURRELL, DE
    MILLER, MA
    CHEMOTHERAPY, 1990, 36 (01) : 8 - 12
  • [3] EVALUATION OF A CONTROLLED-RELEASE MEMBRANE INFUSION DEVICE FOR DELIVERY OF GENTAMICIN
    NAHATA, MC
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 1989, 45 (02) : 162 - 162
  • [4] A scalable controlled-release device for transscleral drug delivery to the retina
    Kawashima, Takeaki
    Nagai, Nobuhiro
    Kaji, Hirokazu
    Kumasaka, Norihiro
    Onami, Hideyuki
    Ishikawa, Yumi
    Osumi, Noriko
    Nishizawa, Matsuhiko
    Abe, Toshiaki
    BIOMATERIALS, 2011, 32 (07) : 1950 - 1956
  • [5] Controlled-release oral delivery systems
    Fix, Joseph A.
    Sako, Kazuhiro
    Sawada, Toyohiro
    ACS Symposium Series, 2000, 752 : 14 - 24
  • [6] CONTROLLED-RELEASE TRANSDERMAL DRUG DELIVERY
    KELLY, HW
    CUTIS, 1985, 35 (03): : 204 - &
  • [7] OVERVIEW OF CONTROLLED-RELEASE DRUG DELIVERY
    LEE, PI
    GOOD, WR
    ACS SYMPOSIUM SERIES, 1987, 348 : 1 - 13
  • [8] ACCURACY OF DELIVERY OF CEFAZOLIN, CHLORAMPHENICOL, AND VANCOMYCIN BY A CONTROLLED-RELEASE MEMBRANE INFUSION DEVICE
    NAHATA, MC
    DURRELL, DE
    MILLER, MA
    AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1988, 45 (11): : 2358 - 2360
  • [9] DISPOSABLE CONTROLLED-RELEASE DEVICE FOR DRUG INFUSION
    WANG, PY
    LEE, MCY
    SMITH, MSM
    ACS SYMPOSIUM SERIES, 1987, 348 : 341 - 350
  • [10] Application of Calcium Phosphate as a Controlled-Release Device
    Ito, Tomoko
    Otsuka, Makoto
    BIOLOGICAL & PHARMACEUTICAL BULLETIN, 2013, 36 (11) : 1676 - 1682